• X
FreeOx
  • ABOUT
  • TEAM
  • PIPELINE
  • PARTNERSHIPS
  • NEWS
  • CONTACT US
Select Page
FreeOx Biotech takes on Xavier Luria as strategic partner

FreeOx Biotech takes on Xavier Luria as strategic partner

by freeoxbio-admin | Feb 27, 2018 | News

FreeOx Biotech has taken on Xavier Luria as its new partner and strategy advisor in a bid to accelerate development and the regulatory process for its main drug candidate, Ox-01, to treat stroke. Luria is a world-renowned expert in clinical and regulatory drug...
http://freeoxbiotech.com/wp-content/uploads/2018/02/DrChamorro_AragonRadio.mp4

Entrevista al Dr. Chamorro en Aragón Radio

by freeoxbio-admin | Feb 6, 2018 | News

Carlos Lurigados: La clave principal de éxito de cualquier proyecto es el equipo

by freeoxbio-admin | Jul 17, 2017 | News

Carlos Lurigados Socio fundador y director general de FreeOx Biotech Veterinario y farmacéutico por la UAB y con un Master de Gestión de Proyectos por La Salle-URL, Carlos Lurigados ha trabajado desarrollando fármacos y consiguiendo licenciarse a...
El ácido úrico aumenta la cifra de pacientes de ictus que quedan libres de secuelas

El ácido úrico aumenta la cifra de pacientes de ictus que quedan libres de secuelas

by freeoxbio-admin | Jun 6, 2017 | News

El neurólogo Ángel Chamorro, del Hospital Clínic, asegura que los enfermos que sufren una trombosis cerebral y tienen altos niveles de esa sustancia en la sangre, sobreviven autónomos. -¿Cómo descubrió que el ácido úrico mejora la resolución de un ictus y elimina sus...

Chamorro Telediario TV1

by freeoxbio-admin | May 28, 2017 | News

« Older Entries
Next Entries »
  • X
© 2023 FREEOX • Terms of use • Privacy policy • Cookies policy
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}